Nearly 40% of healthcare workers say it’s ‘not likely’ they will get a coronavirus vaccine because they are afraid the jabs were developed too quickly to be safe A recent CDC survey found that 37% of healthcare workers say they…
Read More
BioNTech, Pfizer ask Europe to OK vaccine for emergency use
The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. The two companies said Tuesday that the submission, which occurred Monday, completes…
Read More
Germany hits million virus cases as vaccine doubt emerges
Germany, once a beacon of hope in Europe’s coronavirus nightmare, logged its one millionth case on Friday, as questions emerged over just how much protection is offered by one of the leading vaccine candidates. Like much of the continent, Germany…
Read More
Value of vaccine to end COVID-19 pandemic worth 5% to 15% of global wealth
The monetary value of a vaccine that could potentially end the COVID-19 pandemic is between 5%-15% of worldwide wealth, according to a new paper co-written by a University of Illinois Urbana-Champaign business professor. The value of a vaccine rises substantially…
Read More
Covid vaccine: Dr Hilary shares Oxford vaccine side effects – ‘headache and fatigue’
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. The Oxford coronavirus vaccine is the latest hopeful candidate in the race to inoculate the globe against…
Read More
Covid vaccine: Dr Hilary shares latest immunity forecast on coronavirus Oxford vaccine
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Coronavirus vaccine developments are coming thick and fast, raising hopes that COVID-19 – the viral disease sweeping…
Read More
Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness
NEW YORK, 16 November 2020 — Pfizer (NYSE: PFE) today announced the U.S. COVID-19 Immunization Pilot Program with four states, to help refine the plan for the delivery and deployment of the company’s COVID-19 vaccine candidate that is being co-developed with BioNTech. To build…
Read More
Should a COVID-19 vaccine be mandated?
Now that two drug makers—Pfizer and Moderna—have reported highly effective results for their COVID-19 vaccines, it will be only a matter of time until they seek federal permission to release them for public consumption. If FDA approved, one of the…
Read More
Why we should prioritise older people when we get a COVID vaccine
While we wait for further results from phase 3 trials, it’s clear that supply of any potential COVID vaccine would initially be limited. Local authorities will need to prioritize distribution to specific groups, at least at first. So how might…
Read More
Ingredients in flu vaccine won’t hurt you—two pharmacists explain why
Misunderstandings about flu vaccines have existed for decades, leading to vaccine mistrust and lower-than-ideal vaccination rates. Now that a coronavirus vaccine appears to be close, experts are concerned that the lack of trust and understanding about flu vaccines could translate…
Read More